The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer

INTRODUCTION: To investigate the influences of time interval between multimodality therapies on survival for locally advanced gastric cancer (LAGC) patients, 627 patients were included in a retrospective study, and 350 who received neoadjuvant chemotherapy (NACT) based on SOX (S-1 plus Oxaliplatin)/...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun-Bing, Liu, Zi-Ning, Wang, Yin-Kui, Shan, Fei, Li, Shuang-Xi, Jia, Yong-Ning, Xue, Kan, Miao, Ru-Lin, Li, Zhe-Min, Wu, Zhou-Qiao, Ying, Xiang-Ji, Zhang, Yan, Li, Zi-Yu, Ji, Jia-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816861/
https://www.ncbi.nlm.nih.gov/pubmed/36620591
http://dx.doi.org/10.3389/fonc.2022.956706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816861/
https://www.ncbi.nlm.nih.gov/pubmed/36620591
http://dx.doi.org/10.3389/fonc.2022.956706

Ejemplares similares